Global EditionASIA 中文双语Français
China
Home / China / The fight against novel coronavirus

Zimbabwe locks down central city amid COVID-19 variant threat

Xinhua | Updated: 2021-05-22 10:52
Share
Share - WeChat
A nurse prepares a dose of the Sinopharm coronavirus disease (COVID-19) vaccine at Wilkins Hospital in Harare, Zimbabwe, March 24, 2021. [Photo/Agencies]

HARARE - The Zimbabwean government has decided to lock down the central city of Kwekwe for two weeks starting from Friday after the detection of a coronavirus variant first identified in India.

Various measures have been implemented in the city to curb the spread of the variant, including a curfew, closure of bars and a ban on all public gatherings, Vice-President and Health Minister Constantino Chiwenga said in a statement Friday.

"Travelers through Kwekwe are strongly advised to spend as little time as possible in Kwekwe during the next two weeks," he said.

The government identified the COVID-19 variant B.1.617.2 on Wednesday in samples taken from a Kwekwe man who died last week after contact with a relative who had returned from India and tested positive.

The B.1.617 variant, first found in India, has been classified as a "variant of concern" by the World Health Organization as it is more transmissible.

Chiwenga said the first COVID-19 case in the city was reported on May 9.

To date, Zimbabwe has recorded 38,635 COVID-19 cases, 36,427 recoveries and 1,582 deaths.

A total of 615,296 people have received their first dose of a COVID-19 vaccine and 252,100 people have been fully vaccinated.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US